Notably, EVs derived from thymol-treated S. aureus or Lactobacillus plantarum alleviated the AD-like skin lesions including epidermal thickening and IL-4 level 171, 172, indicating their potential to treat AD. This evidence concerns the gene IL4 and Alzheimer disease.